Standout Papers
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression (2017)
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study (2019)
Immediate Impact
3 from Science/Nature 55 standout
Citing Papers
Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors
2025 StandoutNature
Management of Depression in Adults
2024 Standout
Works of Kimberly Cooper being referenced
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
2019 Standout
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kimberly Cooper | 1191 | 838 | 330 | 449 | 25 | 1.8k | |
| Maggie Fedgchin | 1676 | 1226 | 411 | 380 | 24 | 2.0k | |
| Sarah Pillemer | 1246 | 1011 | 273 | 451 | 13 | 1.9k | |
| Lee C. Chang | 1591 | 1265 | 358 | 380 | 17 | 2.1k | |
| Rayan K. Al Jurdi | 1110 | 936 | 256 | 605 | 20 | 1.8k | |
| Lawrence T. Park | 851 | 846 | 234 | 256 | 36 | 1.8k | |
| Rosanne Lane | 1718 | 1152 | 497 | 1174 | 41 | 3.0k | |
| Charles R. Conway | 774 | 369 | 182 | 567 | 63 | 2.3k | |
| Jennifer L. Vande Voort | 789 | 616 | 345 | 532 | 80 | 1.9k | |
| Benji T. Kurian | 1085 | 588 | 619 | 530 | 38 | 2.1k | |
| Bashkim Kadriu | 881 | 986 | 274 | 298 | 57 | 2.4k |
All Works
Loading papers...